469 related articles for article (PubMed ID: 18188453)
1. Muramyl dipeptide activation of nucleotide-binding oligomerization domain 2 protects mice from experimental colitis.
Watanabe T; Asano N; Murray PJ; Ozato K; Tailor P; Fuss IJ; Kitani A; Strober W
J Clin Invest; 2008 Feb; 118(2):545-59. PubMed ID: 18188453
[TBL] [Abstract][Full Text] [Related]
2. The effect of NOD2 activation on TLR2-mediated cytokine responses is dependent on activation dose and NOD2 genotype.
Borm ME; van Bodegraven AA; Mulder CJ; Kraal G; Bouma G
Genes Immun; 2008 Apr; 9(3):274-8. PubMed ID: 18340358
[TBL] [Abstract][Full Text] [Related]
3. Engagement of NOD2 has a dual effect on proIL-1beta mRNA transcription and secretion of bioactive IL-1beta.
Ferwerda G; Kramer M; de Jong D; Piccini A; Joosten LA; Devesaginer I; Girardin SE; Adema GJ; van der Meer JW; Kullberg BJ; Rubartelli A; Netea MG
Eur J Immunol; 2008 Jan; 38(1):184-91. PubMed ID: 18157816
[TBL] [Abstract][Full Text] [Related]
4. Human umbilical cord blood mesenchymal stem cells reduce colitis in mice by activating NOD2 signaling to COX2.
Kim HS; Shin TH; Lee BC; Yu KR; Seo Y; Lee S; Seo MS; Hong IS; Choi SW; Seo KW; Núñez G; Park JH; Kang KS
Gastroenterology; 2013 Dec; 145(6):1392-403.e1-8. PubMed ID: 23973922
[TBL] [Abstract][Full Text] [Related]
5. Impaired dendritic cell function in Crohn's disease patients with NOD2 3020insC mutation.
Kramer M; Netea MG; de Jong DJ; Kullberg BJ; Adema GJ
J Leukoc Biol; 2006 Apr; 79(4):860-6. PubMed ID: 16461743
[TBL] [Abstract][Full Text] [Related]
6. NOD2 transgenic mice exhibit enhanced MDP-mediated down-regulation of TLR2 responses and resistance to colitis induction.
Yang Z; Fuss IJ; Watanabe T; Asano N; Davey MP; Rosenbaum JT; Strober W; Kitani A
Gastroenterology; 2007 Nov; 133(5):1510-21. PubMed ID: 17915219
[TBL] [Abstract][Full Text] [Related]
7. Nod2 improves barrier function of intestinal epithelial cells via enhancement of TLR responses.
Hiemstra IH; Bouma G; Geerts D; Kraal G; den Haan JM
Mol Immunol; 2012 Oct; 52(3-4):264-72. PubMed ID: 22750073
[TBL] [Abstract][Full Text] [Related]
8. Regulation of IL-8 and IL-1beta expression in Crohn's disease associated NOD2/CARD15 mutations.
Li J; Moran T; Swanson E; Julian C; Harris J; Bonen DK; Hedl M; Nicolae DL; Abraham C; Cho JH
Hum Mol Genet; 2004 Aug; 13(16):1715-25. PubMed ID: 15198989
[TBL] [Abstract][Full Text] [Related]
9. Blau syndrome NOD2 mutations result in loss of NOD2 cross-regulatory function.
Mao L; Dhar A; Meng G; Fuss I; Montgomery-Recht K; Yang Z; Xu Q; Kitani A; Strober W
Front Immunol; 2022; 13():988862. PubMed ID: 36189261
[TBL] [Abstract][Full Text] [Related]
10. Characterization of nucleotide-binding oligomerization domain (NOD) protein expression in primary murine microglia.
Sterka D; Marriott I
J Neuroimmunol; 2006 Oct; 179(1-2):65-75. PubMed ID: 16842862
[TBL] [Abstract][Full Text] [Related]
11. NOD2 downregulates colonic inflammation by IRF4-mediated inhibition of K63-linked polyubiquitination of RICK and TRAF6.
Watanabe T; Asano N; Meng G; Yamashita K; Arai Y; Sakurai T; Kudo M; Fuss IJ; Kitani A; Shimosegawa T; Chiba T; Strober W
Mucosal Immunol; 2014 Nov; 7(6):1312-25. PubMed ID: 24670424
[TBL] [Abstract][Full Text] [Related]
12. Nucleotide binding oligomerization domain 2 deficiency leads to dysregulated TLR2 signaling and induction of antigen-specific colitis.
Watanabe T; Kitani A; Murray PJ; Wakatsuki Y; Fuss IJ; Strober W
Immunity; 2006 Sep; 25(3):473-85. PubMed ID: 16949315
[TBL] [Abstract][Full Text] [Related]
13. Colonic expression of the peptide transporter PEPT1 is downregulated during intestinal inflammation and is not required for NOD2-dependent immune activation.
Wuensch T; Ullrich S; Schulz S; Chamaillard M; Schaltenberg N; Rath E; Goebel U; Sartor RB; Prager M; Büning C; Bugert P; Witt H; Haller D; Daniel H
Inflamm Bowel Dis; 2014 Apr; 20(4):671-84. PubMed ID: 24583477
[TBL] [Abstract][Full Text] [Related]
14. TLR- and NOD2-dependent regulation of human phagocyte-specific chitotriosidase.
van Eijk M; Scheij SS; van Roomen CP; Speijer D; Boot RG; Aerts JM
FEBS Lett; 2007 Nov; 581(28):5389-95. PubMed ID: 17976376
[TBL] [Abstract][Full Text] [Related]
15. Microbial induction of CARD15 expression in intestinal epithelial cells via toll-like receptor 5 triggers an antibacterial response loop.
Begue B; Dumant C; Bambou JC; Beaulieu JF; Chamaillard M; Hugot JP; Goulet O; Schmitz J; Philpott DJ; Cerf-Bensussan N; Ruemmele FM
J Cell Physiol; 2006 Nov; 209(2):241-52. PubMed ID: 16897777
[TBL] [Abstract][Full Text] [Related]
16. Species-specific engagement of human nucleotide oligomerization domain 2 (NOD)2 and Toll-like receptor (TLR) signalling upon intracellular bacterial infection: role of Crohn's associated NOD2 gene variants.
Salem M; Seidelin JB; Eickhardt S; Alhede M; Rogler G; Nielsen OH
Clin Exp Immunol; 2015 Mar; 179(3):426-34. PubMed ID: 25335775
[TBL] [Abstract][Full Text] [Related]
17. NOD2/CARD15 on bone marrow CD34+ hematopoietic cells mediates induction of cytokines and cell differentiation.
Sioud M; Fløisand Y
J Leukoc Biol; 2009 Jun; 85(6):939-46. PubMed ID: 19244164
[TBL] [Abstract][Full Text] [Related]
18. Expression, regulation, and signaling of the pattern-recognition receptor nucleotide-binding oligomerization domain 2 in rheumatoid arthritis synovial fibroblasts.
Ospelt C; Brentano F; Jüngel A; Rengel Y; Kolling C; Michel BA; Gay RE; Gay S
Arthritis Rheum; 2009 Feb; 60(2):355-63. PubMed ID: 19180502
[TBL] [Abstract][Full Text] [Related]
19. VIP balances innate and adaptive immune responses induced by specific stimulation of TLR2 and TLR4.
Arranz A; Juarranz Y; Leceta J; Gomariz RP; Martínez C
Peptides; 2008 Jun; 29(6):948-56. PubMed ID: 18359536
[TBL] [Abstract][Full Text] [Related]
20. IRF4 selectively controls cytokine gene expression in chronic intestinal inflammation.
Mudter J; Yu J; Amoussina L; Weigmann B; Hoffman A; Rücknagel K; Galle PR; Neurath MF
Arch Immunol Ther Exp (Warsz); 2009; 57(5):369-76. PubMed ID: 19693649
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
